Overview Submission Instructions Recent Publications Frequently Asked Questions Research Topics

Looking to publish in Molecular Medicine Reports? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login

Molecular Medicine Reports

Molecular Medicine Reports covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery. Print ISSN: 1791-2997. Online ISSN: 1791-3004.

Looking to publish in Molecular Medicine Reports? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login

Subject Medicine, Research & Experimental, Oncology

Impact Factor 3.5

Quartile Q2

Open Access Type Hybrid

ISSN 1791-2997

eISSN 1791-3004

Invitation Only No

Cost Range Option 1: €550 for up to 5 pages, plus €110 for each additional page and €390 per color page; articles become freely available 12 months after print publication. Option 2: €1,890 / £1,600 / $1,890 for immediate open access.

Submission Instructions

Molecular Medicine Reports accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter A cover letter is required. The cover letter must briefly summarize the study and confirm originality, novelty, approval by all authors, and disclosure of any competing interests.

Abstract An abstract is required. Abstract is usually 150-300 words. Abstract must be continuous and unstructured. Abstract must not contain subsections such as Objectives, Methods, Results or Conclusions.

Manuscript Original Research Articles must include Abstract, Introduction, Materials and methods, Results, Discussion, Acknowledgements, Funding, Availability of data and materials, Authors' contributions, Ethics approval and consent to participate, Patient consent for publication, Competing interests, References, Figure legends, and Tables. The manuscript must include 5 to 10 keywords, a running title of no more than 100 characters including the author name, all required declaration sections with 'Use of artificial intelligence tools' only when AI tools are used, and an optional Authors' information section.

References References must be numbered consecutively in order of appearance, cited in the text using numbers in parentheses, use NLM journal title abbreviations, list the first 9 authors or the first 10 followed by et al when more than 10 authors exist, and include inclusive page numbers.

Figures & Tables Figure legends must be included in the text document separate from the figure files, and each table must be submitted as a separate Word file. All figures and tables must be cited in the Results section, figure legends must include a title and brief description, graphs must label axes and define significance indicators and error bars, and microscopy legends should state image type and original magnification and/or scale bar length.

Reformat to Molecular Medicine Reports using Livewrite Premium

Review Articles

Cover Letter A cover letter is required. Cover letter must briefly summarize the important points of the work and study description, confirm author approval and originality, and disclose any competing interests.

Abstract Abstract is required. Abstract is usually 150-300 words. Abstract must be continuous and unstructured, with no subsections. Abstract must not contain references.

Manuscript Review Articles may use subject-specific sections and subheadings, but must include a numbered Contents section immediately after the Abstract and the sections Abstract, Acknowledgements, Funding, Availability of data and materials, Authors' contributions, Ethics approval and consent to participate, Patient consent for publication, Competing interests, References, Figure legends, and Tables. Manuscript must include 5 to 10 keywords, include 'Not applicable' in the Availability of data and materials section, and include a Use of artificial intelligence tools section only when AI tools are used.

References References must be numbered consecutively in order of appearance, cited in the text using numbers in parentheses, use NLM journal title abbreviations, and list the first 10 authors followed by et al. when more than 10 authors are present.

Figures & Tables Figure legends must be included in the text document, and each table must be submitted in a separate Word file. Tables must be labeled using Roman numerals and given a short title immediately before each table.

Reformat to Molecular Medicine Reports using Livewrite Premium

Recent Publications

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analyses

Yun Wen, Pengfei Luo

10.3892/mmr.2026.13970

View Publication

Chronic kidney disease‑associated encephalopathy: Clinical features, pathomechanisms and emerging therapeutic strategies (Review)

Nanling Zeng, Ling Jiang, Yang Zhang, Jian Liu, Qiong Zhang, Lishang Liao, Qiongdan Hu

10.3892/mmr.2026.13969

View Publication

[Retracted] Emodin promotes the arrest of human lymphoma Raji cell proliferation through the UHRF1‑DNMT3A‑∆Np73 pathways

Yun Lin, Weiming Chen, Zhihong Wang, Pengwei Cai

10.3892/mmr.2026.13968

View Publication

Sedanolide alleviates LPS‑induced depressive‑like behaviors by modulating the C3a/C3aR signaling axis and microglial glycolysis

Shaocong Lu, Fangla Luo, Niqi Chen, Gongde Shi, Yeru Chen

10.3892/mmr.2026.13967

View Publication

[Expression of Concern] Chrysophanol inhibits proliferation and induces apoptosis through NF‑κB/cyclin D1 and NF‑κB/Bcl‑2 signaling cascade in breast cancer cell lines

Li Ren, Zhouping Li, Chunmei Dai, Danyu Zhao, Yanjie Wang, Chunyu Ma, Chun Liu

10.3892/mmr.2026.13966

View Publication

Frequently asked questions

How long does it take to publish?

Articles become freely available 12 months after print publication. Agency-funded articles without open access purchase are deposited and made publicly available in PubMed Central and Europe PMC 6-12 months following publication, depending on funder policy.

Reformat to Molecular Medicine Reports using Livewrite Premium

Is a cover letter required?

A cover letter is required for all submissions. It should briefly summarize the submitted work and confirm originality, that the manuscript has not been previously submitted to or accepted by another journal, that all authors approved the submission, that ethics approval and written informed consent were obtained where applicable, and that any competing interests are disclosed.

Reformat to Molecular Medicine Reports using Livewrite Premium

What are the publication costs?

Molecular Medicine Reports offers two publication options: page-based charges of €550 for up to 5 pages plus €110 for each additional page, with €390 per color page, or immediate open access for €1,890 / £1,600 / $1,890.

Reformat to Molecular Medicine Reports using Livewrite Premium

Research Topics

MicroRNA in disease regulation Cancer-related molecular mechanisms research Circular RNAs in diseases RNA modifications and cancer Autophagy in Disease and Therapy RNA Research and Splicing Cancer, Hypoxia, and Metabolism Mesenchymal stem cell research Epigenetics and DNA Methylation Immune Response and Inflammation RNA Interference and Gene Delivery Cell death mechanisms and regulation Bone Metabolism and Diseases Cancer-related Molecular Pathways NF-κB Signaling Pathways Cancer-related gene regulation Neuroinflammation and Neurodegeneration Mechanisms Cancer Cells and Metastasis Cancer Mechanisms and Therapy Cell Adhesion Molecules Research Endoplasmic Reticulum Stress and Disease Liver Disease Diagnosis and Treatment Immune Cell Function and Interaction Genomics, phytochemicals, and oxidative stress Natural product bioactivities and synthesis

Related Journals

Journal of Hepatocellular Carcinoma Dove Medical Press

Gene Therapy Springer Nature

Cancer Medicine WILEY

Clinical and Experimental Medicine Springer Science+Business Media

Molecular Genetics and Metabolism Elsevier BV

Life Sciences Elsevier BV